|
2BQ0
14-3-3 Protein Beta (Human)
Deposited 2005-04-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–238(238 aa)
Chain B
1–238(238 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8;0.05M MGCL2,0.1M HEPES PH7.5, 30% PEG MME 550, pH 8.00
|
Resolution 2.50 Å
R-free 0.273
|
|
2BQ0
14-3-3 Protein Beta (Human)
Deposited 2005-04-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–238(238 aa)
Chain B
1–238(238 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8;0.05M MGCL2,0.1M HEPES PH7.5, 30% PEG MME 550, pH 8.00
|
Resolution 2.50 Å
R-free 0.273
|
|
2C23
14-3-3 Protein Beta (Human) in complex with exoenzyme S peptide
Deposited 2005-09-26
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
1–238(238 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8;0.05M MGCL2,0.1M HEPES PH7.5, 30% PEG MME 550, pH 8.00
|
Resolution 2.65 Å
R-free 0.286
|
|
4DNK
Crystal structure of a tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide (YWHAB) from homo sapiens at 2.20 A resolution.
Deposited 2012-02-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–246(246 aa)
Chain B
1–246(246 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
PO4 PHOSPHATE ION × 3
EDO 1,2-ETHANEDIOL × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277 K;20.00% polyethylene glycol 3350, 0.20M magnesium acetate, NANODROP, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
Resolution 2.20 Å
R-free 0.226
|
|
5N10
Cucurbit[8]uril and 14-3-3 based binary bivalent supramolecular-protein assembly platform
Deposited 2017-02-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain A
1–246(246 aa)
Chain B
1–246(246 aa)
|
Not recorded
|
GOL GLYCEROL × 1
C8L Cucurbit[8]uril × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;277.15 K;PEG 1500, sodium citrate
|
Resolution 1.60 Å
R-free 0.194
|
|
6A5Q
Structure of 14-3-3 beta in complex with TFEB 14-3-3 binding motif
Deposited 2018-06-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
1–246(246 aa)
Chain B
1–246(246 aa)
|
Not recorded
|
MLA MALONIC ACID × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;pH 4;289 K;0.1 M sodium malonate, and 12% (w/v) PEG 3350
|
Resolution 2.00 Å
R-free 0.230
|
|
6A5Q
Structure of 14-3-3 beta in complex with TFEB 14-3-3 binding motif
Deposited 2018-06-25
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
1–246(246 aa)
|
Not recorded
|
MLA MALONIC ACID × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;pH 4;289 K;0.1 M sodium malonate, and 12% (w/v) PEG 3350
|
Resolution 2.00 Å
R-free 0.230
|
|
6GN0
Exoenzyme S from Pseudomonas aeruginosa in complex with human 14-3-3 protein beta, tetrameric crystal form
Deposited 2018-05-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
1–239(239 aa)
Chain B
1–239(239 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5;277 K;12% PEG 3350, 4% Tacsimate
|
Resolution 3.24 Å
R-free 0.294
|
|
6GN0
Exoenzyme S from Pseudomonas aeruginosa in complex with human 14-3-3 protein beta, tetrameric crystal form
Deposited 2018-05-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
1–239(239 aa)
Chain D
1–239(239 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5;277 K;12% PEG 3350, 4% Tacsimate
|
Resolution 3.24 Å
R-free 0.294
|
|
6GN8
Exoenzyme S from Pseudomonas aeruginosa in complex with human 14-3-3 protein beta, trimeric crystal form
Deposited 2018-05-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–234(234 aa)
Chain B
1–234(234 aa)
|
Not recorded
|
MPD (4S)-2-METHYL-2,4-PENTANEDIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;40% MPD, 8% PEG 8000, 0.1M Sodium Cacodylate
|
Resolution 2.34 Å
R-free 0.248
|
|
6GNJ
Exoenzyme S from Pseudomonas aeruginosa in complex with human 14-3-3 protein beta, trimeric crystal form in complex with STO1101
Deposited 2018-05-31
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–234(234 aa)
Chain B
1–234(234 aa)
|
Not recorded
|
F4W 3-(12-oxidanylidene-7-thia-9,11-diazatricyclo[6.4.0.0^{2,6}]dodeca-1(8),2(6),9-trien-10-yl)propanoic acid × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;40% MPD, 7% PEG 8000, 0.1M Sodium Cacodylate
|
Resolution 3.24 Å
R-free 0.221
|
|
6GNK
Exoenzyme S from Pseudomonas aeruginosa in complex with human 14-3-3 protein beta, trimeric crystal form bound to Carba-NAD
Deposited 2018-05-31
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–234(234 aa)
Chain B
1–234(234 aa)
|
Not recorded
|
CNA CARBA-NICOTINAMIDE-ADENINE-DINUCLEOTIDE × 1
MPD (4S)-2-METHYL-2,4-PENTANEDIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;50% MPD, 8% PEG 8000, 0.1M Sodium Cacodylate
|
Resolution 2.55 Å
R-free 0.239
|
|
6GNN
Exoenzyme T from Pseudomonas aeruginosa in complex with human 14-3-3 protein beta, tetrameric crystal form bound to STO1101
Deposited 2018-05-31
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
1–239(239 aa)
|
Not recorded
|
F4W 3-(12-oxidanylidene-7-thia-9,11-diazatricyclo[6.4.0.0^{2,6}]dodeca-1(8),2(6),9-trien-10-yl)propanoic acid × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5;293 K;12% PEG 6000, 0.1M Citrate
|
Resolution 3.79 Å
R-free 0.385
|
|
6HEP
Crystal structure of human 14-3-3 beta in complex with CFTR R-domain peptide pS753-pS768
Deposited 2018-08-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–232(232 aa)
Chain B
1–232(232 aa)
|
Not recorded
|
ETE 2-{2-[2-2-(METHOXY-ETHOXY)-ETHOXY]-ETHOXY}-ETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;278 K;0.1M Tris, 25% v/v PEG350 MME
|
Resolution 1.86 Å
R-free 0.251
|
|
6HEP
Crystal structure of human 14-3-3 beta in complex with CFTR R-domain peptide pS753-pS768
Deposited 2018-08-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–232(232 aa)
Chain D
1–232(232 aa)
|
Not recorded
|
ETE 2-{2-[2-2-(METHOXY-ETHOXY)-ETHOXY]-ETHOXY}-ETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;278 K;0.1M Tris, 25% v/v PEG350 MME
|
Resolution 1.86 Å
R-free 0.251
|
|
6YGJ
small-molecule stabilizer of 14-3-3 and the Carbohydrate Response Element Binding Protein (ChREBP) protein-protein interaction
Deposited 2020-03-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
4–232(229 aa)
Chain F
2–232(231 aa)
|
Not recorded
|
OQE [2-[2-oxidanylidene-2-(2-phenylethylamino)ethoxy]phenyl]phosphonic acid × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;295 K;0.1M HEPES (pH 7.1), 30% MPD, 1% PEG 4000, 0.1 M Ni(II)Cl 6H2O
|
Resolution 2.07 Å
R-free 0.277
|
|
8DP5
Structure of the PEAK3/14-3-3 complex
Deposited 2022-07-14
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain C
1–246(246 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;A final concentration of 0.1% of Octyl-beta-Glucoside (C14H28O6) was added to the sample before freezing.
cryo-EM vitrification conditions
Cryogen ETHANE;blot time = 7s
blot force = 4
|
Resolution 3.10 Å
|
|
8EQ8
The crystal structure of 14-3-3 Beta containing 3-nitrotyrosine at position Y130
Deposited 2022-10-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–239(239 aa)
Chain B
1–239(239 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;20%-30% PEG 550 MME, 50 mM MgCl2, 100 mM HEPES pH 7-8.3
|
Resolution 1.50 Å
R-free 0.205
|
|
8EQH
The crystal structure of 14-3-3 Beta containing 3-nitrotyrosine at position Y213
Deposited 2022-10-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–239(239 aa)
Chain B
1–239(239 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;20%-27% PEG 3350, +/- 50 mM MgCl2, 100 mM Bis-Tris pH 5.5-6.5
|
Resolution 1.90 Å
R-free 0.218
|
|
9GCP
ChREBP/14-3-3 complex stabilized by AMP
Deposited 2024-08-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
3–232(230 aa)
Chain E
3–232(230 aa)
|
Not recorded
|
AMP ADENOSINE MONOPHOSPHATE × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;293 K;50 mM MES ph 6.0 2.2M Sodium Malonate
|
Resolution 2.59 Å
R-free 0.271
|
|
9GCP
ChREBP/14-3-3 complex stabilized by AMP
Deposited 2024-08-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
3–232(230 aa)
Chain G
3–232(230 aa)
|
Not recorded
|
AMP ADENOSINE MONOPHOSPHATE × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;293 K;50 mM MES ph 6.0 2.2M Sodium Malonate
|
Resolution 2.59 Å
R-free 0.271
|